Salud financiera de hoja de balance de Artiva Biotherapeutics
Salud financiera controles de criterios 4/6
Artiva Biotherapeutics has a total shareholder equity of $25.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $75.9M and $50.6M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$46.56m |
| Patrimonio | US$25.32m |
| Total pasivo | US$50.60m |
| Activos totales | US$75.91m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Análisis de la situación financiera
Pasivos a corto plazo: ARTV's short term assets ($49.7M) exceed its short term liabilities ($10.8M).
Pasivo a largo plazo: ARTV's short term assets ($49.7M) exceed its long term liabilities ($39.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: ARTV is debt free.
Reducción de la deuda: ARTV had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: ARTV has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: ARTV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 36.3% each year